17 results
424B5
IPHA
Innate Pharma
6 Feb 24
Prospectus supplement for primary offering
5:00pm
products, media or critical raw materials), (c) research and development activities related to critical technologies (including cybersecurity, artificial … , space, telecom, public health, farm products, media or critical raw materials), (c) research and development activities related to critical
20-F
jvz4biraiec9yi 83f
24 Apr 20
Annual report (foreign)
10:43am
424B4
mzkpe3fn 5jcljh
18 Oct 19
Prospectus supplement with pricing info
4:08pm
F-1/A
755oms ymf54w9e
4 Oct 19
Registration statement (foreign) (amended)
4:56pm
F-1
db6ytfbd2tlk4dn5 m4
20 Sep 19
Registration statement (foreign)
4:08pm
F-1
EX-10.3
fnket
20 Sep 19
Registration statement (foreign)
4:08pm
F-1
EX-10.1
asi8guy6jln bde4
20 Sep 19
Registration statement (foreign)
4:08pm
DRS/A
EX-10.3
q8ymw
30 Aug 19
Draft registration statement (amended)
12:00am
DRS/A
EX-10.1
wst680sdzse7 p1x
30 Aug 19
Draft registration statement (amended)
12:00am
DRS/A
0ewyrtqgco9 ph3
30 Aug 19
Draft registration statement (amended)
12:00am
DRS/A
y3epakpxbn9wd
19 Jul 19
Draft registration statement (amended)
12:00am
DRS
8zmme1am
10 Jun 19
Draft registration statement
12:00am
- Prev
- 1
- Next